Skip to content
HowShorted

Acadia Healthcare Company, Inc. short interest in 2023

In 2023, Acadia Healthcare Company, Inc.'s disclosed short interest ran from 3.74% of shares outstanding on 13 Jan 2023 to 3.25% on 29 Dec 2023, a change of -0.49 percentage points. The year's high was 4.96% on 30 Jun 2023 and its low 3.05% on 15 Nov 2023, averaging 3.70% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.62 days on 31 Aug 2023. Full history: Acadia Healthcare Company, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Acadia Healthcare Company, Inc. in 2023

2023 in figures

Start of year
3.74% (13 Jan 2023)
End of year
3.25% (29 Dec 2023)
Change
-0.49 pp
High
4.96% (30 Jun 2023)
Low
3.05% (15 Nov 2023)
Average
3.70%
Highest days to cover
9.62 (31 Aug 2023)
SEC filings marked
8

Every report in 2023

Acadia Healthcare Company, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20233.74%9.42
31 Jan 20234.10%7.73
15 Feb 20233.98%6.26
28 Feb 20234.02%4.98results (8-K), 10-K filed
15 Mar 20234.13%4.76
31 Mar 20234.04%7.47
14 Apr 20233.97%9.19
28 Apr 20233.91%4.52results (8-K), 10-Q filed
15 May 20234.23%6.42
31 May 20234.06%6.31
15 Jun 20234.22%6.02
30 Jun 20234.96%6.03
14 Jul 20234.43%4.56
31 Jul 20233.30%4.18results (8-K), 10-Q filed
15 Aug 20233.08%8.09
31 Aug 20233.16%9.62
15 Sep 20233.10%5.52
29 Sep 20233.24%8.04
13 Oct 20233.14%4.74
31 Oct 20233.17%4.94
15 Nov 20233.05%4.24results (8-K), 10-Q filed
30 Nov 20233.19%8.03
15 Dec 20233.44%5.08
29 Dec 20233.25%9.37

See also: Acadia Healthcare Company, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.